Win or lose, Miss America contestant Allyn Rose made news with her decision to undergo a double mastectomy. According to the Associated Press, Rose, who lost her mother to breast cancer, inherited a rare genetic mutation which might put her at greater risk for developing cancer. Her decision to have the preventive surgery has sparked questions about genetics, cancer risk and strategies for preventing cancer. If you have a question about genetic factors that increase cancer risk, you can ask the Dana-Farber cancer genetics team.
by Nancy Campbell, MS “How soon can I start exercising after I start cancer treatment?” It’s a question I hear often from patients who visit me for a fitness consult or class at Dana-Farber. My answer? “As soon as possible.” While it may seem counterintuitive, exercise offers key benefits for cancer patients – even those undergoing difficult treatments. In fact, it’s one of the best ways to give yourself an extra boost during and after cancer treatment.
For David Williams, MD, the field of pediatrics offers two great attractions. “It is wonderful because of the kinds of patients you take care of,” he says. “But also because of the personalities of pediatricians – in pediatrics you find very compassionate and caring people.” Williams embodies that compassion and combines it with a drive to solve the medical problems of young patients, often with the use of cutting-edge technology.
When Jane Davis was diagnosed with breast cancer last July, she began learning as much as she could about her disease. Davis quickly discovered one of the most startling statistics about breast cancer: Up to 40 percent of women who have a lumpectomy require a second surgery. That’s because surgeons often cannot microscopically remove the entire tumor. But Mehra Golshan, MD, FACS, director of Breast Surgical Services at Dana-Farber/Brigham and Women’s Cancer Center, is trying to change that with a phase I breast surgery pilot study. It’s the first of its kind in the world.
Asking an editor to pick his or her favorite story is like asking a kid to pick out just one piece of candy. It’s a tough task. Luckily, we’re not bound by the one-piece rule. So here are a few stories that you might have missed, or might want to view again.
by Sara Dickison Taylor You wouldn’t be able to tell just by meeting them, but high-school student Molly Callahan and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center nurse Lindsay Roache, RN, have a few things in common: They’ve survived cancer, and they’re committed to helping others.
When it comes to treating prostate cancer, proton radiotherapy (PRT) is no better than traditional intensity-modulated radiation therapy (IMRT), according to a new study reported in the Journal of the National Cancer Institute on Friday. PRT is an advanced but expensive treatment option for some prostate cancer patients. However, the researchers found that the therapy offers no added treatment benefit than the standard therapy. The article concluded: “Although PRT is substantially more costly than IMRT, there was no difference in toxicity in a comprehensive cohort of Medicare beneficiaries with prostate cancer at 12 months post-treatment.”